What does this research mean for the field?

Cardiac-specific myosin light chain kinase (cMLCK) regulates cardiac myocyte contraction by phosphorylating MLC2, which acts as a positive modulator of calcium sensitivity and maximal force response, making it a potential therapeutic target for heart diseases. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

January 1, 2013Circulation JournalOpen Access

Biochemical and Physiological Regulation of Cardiac Myocyte Contraction by Cardiac-Specific Myosin Light Chain Kinase

View Full Paper

Ask AI

Bookmark

Population

Cardiac myocytes (striated muscle cells)

Design

Review

Authors

OTOsamu TsukamotoHyogo University MKMasafumi KitakazeHeart Failure & Transplant

Discussion

Member takes

Implication

May support cMLCK as a heart disease drug target; leaves open clinical translation pending trials.

Structured PICO

Population

Cardiac myocytes (striated muscle cells)

Understanding the biochemical and physiological regulation of cardiac myocyte contraction by cMLCK highlights its potential as a therapeutic target for the development of novel drugs for heart diseases.

Cite This Study

Tsukamoto et al. (2013) studied this question.

synapsesocial.com/papers/6a1bcd690a1f7575939cf29f https://doi.org/10.1253/circj.cj-13-0627

View Full Paper

Ask AI

Bookmark

Biochemical and Physiological Regulation of Cardiac Myocyte Contraction by Cardiac-Specific Myosin Light Chain Kinase

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Biochemical and Physiological Regulation of Cardiac Myocyte Contraction by Cardiac-Specific Myosin Light Chain Kinase

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Also Consider